Table 1 Clinical features and epidemiology data in cases with clonal group O25b/ST131 and control group

Male sex

10(25)

8(40)

0.232

Age

67.0 + -13.9

66.0+/-17.7

0.807

Underlying disease

Diabetes mellitus

16(40.0)

6(30)

0.449

Hepatobiliary disease

16(40.0)

8(40)

1.000

Renal structure abnormality

3 (7.5)

4(20)

0.208

Chronic renal disease

4(10)

4(20)

0.422

Liver cirrhosis

8(20)

2(10)

0.471

Malignancy

8(20)

7(35)

0.206

Bedridden

4(10)

2(10)

1.000

Healthcare-associated risk factor

Hospitalization in previous 6 months

20(50)

6(30)

0.141

Antimicrobials exposure in 3 months

B-lactam antimicrobials

17(42.5)

6(30)

0.102

Fluoroquinolone

0(0)

2(10)

Recent operation

5(12.5)

1(5)

0.653

With Foley catheter

5(12.5)

0(0)

0.159

Infection syndrome

Urinary tract infection

22(55.0)

12(60)

0.713

Intra-abdominal infection

9(22.5)

0(0)

0.023

Outcome

Discordant antimicrobials

5(12.5)

4(20)

0.464

Shock

6(15)

4(20)

0.718

Length of stay >2 weeks

11(27.5)

6(30)

0.839

Day 30 mortality

5(12.5)

3(15)

1.000